HOME >> MEDICINE >> NEWS
Post-stent maintenance therapies questioned

e randomized, multi-center, double-blind, placebo controlled study of 2,022 patients undergoing PCI after pretreatment with clopidogrel were randomized to receive abciximab or placebo. The researchers measured for 30-day combined incidence of death, heart attack or urgent revascularization, as well as bleeding complications. The trial results show the role of the combination - intensive clopidogrel pretreatment plus abciximab - during PCI for ACS. They will enable us to know whether patients with ACS or any subset of them can benefit from this combination.

Dr. Kastrati will present the results of the "Prospective, Double Blind, Placebo-Controlled Trial of Glycoprotein IIb/IIIa Inhibition with Abciximab in Patients with Acute Coronary Syndromes Undergoing Stenting After Pretreatment with a High Loading Dose of Clopidogrel" (ISAR-REACT 2) study on Monday, March 13, at 2:40 p.m.


'"/>


14-Mar-2006


Page: 1 2

Related medicine news :

1. FDA approves Dey, L.P.s Perforomist inhalation solution for maintenance treatment of COPD
2. Internal medicine organizations survey internists on maintenance of certification
3. ASH Self-Assessment Program receives approval for maintenance of certification credit
4. Future therapies for stroke may block cell death
5. Antifolate therapies found effective against certain type of malaria
6. Combined molecular-targeted and hormonal therapies offer promise in treating ovarian cancer
7. A sweet step toward new cancer therapies
8. Psychological therapies for common anxiety disorder not readily available in primary care settings
9. About 5 percent of adults with insomnia use alternative therapies
10. Combined therapies may boost immune response and long-term protection against brain tumors
11. New hope in cancer vaccines emerges as novel therapies are developed and tested

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Post stent maintenance therapies questioned

(Date:8/5/2015)... ... , ... The June 6 opening of Chicago’s new elevated trail, the 606, has been getting ... a group of walkers at Sedgebrook senior living community in Lincolnshire. Known as the ... preserves and twice per month to more distant places. When they read about the ...
(Date:8/5/2015)... ... 05, 2015 , ... What language does a body speak? "Body Language ... idioms and other expressions that contain the name of a body part. , The ... about 2,000 such idioms, words, and expressions, for example, “back against the wall,” “brainstorming,” ...
(Date:8/5/2015)... ... August 05, 2015 , ... ... filed in the testosterone multidistrict litigation known as Testosterone Replacement Therapy Products Liability ... Northern District of Illinois. The Motion to Dismiss was filed by the defendants, ...
(Date:8/5/2015)... ... ... Wildflower Seed & Tool Company ” was featured on NewsWatch as part of its ... impact in their industry. Susan Bridges, a reporter for NewsWatch and a business expert, ... designed for women. , With overweight gardening tools that seem like they’re designed for ...
(Date:8/5/2015)... ... ... Available in select spas and at http://www.lespausa.com , Phytomer ... oils. A perfect complement to Phytomer’s top selling product, ROSÉE VISAGE Cleansing Toning ... soothing properties. Formulated as a light and comfortable dry oil, it quickly penetrates the ...
Breaking Medicine News(10 mins):Health News:Sedgebrook Trailblazers Tread New Ground on Chicago’s New 606 Path 2Health News:Sedgebrook Trailblazers Tread New Ground on Chicago’s New 606 Path 3Health News:Harvard Medical Professor Dr. Per-Olof Hasselgren Pens Unique Book Using Body Part Idioms 2Health News:Testosterone Lawsuit News: Defendants Push Back Against RICO Claim 2Health News:Testosterone Lawsuit News: Defendants Push Back Against RICO Claim 3Health News:Testosterone Lawsuit News: Defendants Push Back Against RICO Claim 4Health News:Wildflower Seed & Tool Company Design Gardening Tools Specifically for Women 2Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 2Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 3Health News:Phytomer launches ROSÉE SOIN Radiance Replenishing Oil 4
(Date:8/4/2015)... SEATTLE , Aug. 4, 2015  Dr. ... Institute states the potential FDA approval of flibanserin, ... sets women and the treatment of decreased female ... women has many root causes and addressing libido ... is dangerous. ...
(Date:8/4/2015)... Pharmaceuticals, Inc. (Nasdaq: ISIS ) today reported net ... three and six months ended June 30, 2015, respectively, ... $43.4 million for the same periods in 2014. Isis, ... more than $90 million of revenue Isis earned in ... Bayer to license  ISIS-FXI Rx .  Isis increased its ...
(Date:8/4/2015)... 2015  Intec Pharma Ltd. (the "Company") (NASDAQ: ... developing drugs based on its proprietary Accordion Pill platform ... offering in the United States ... to the public of $6.00 per ordinary share, before ... are being offered by the Company.  In addition, the ...
Breaking Medicine Technology:Potential FDA Approval of "Pink Viagra" Sends Wrong Message 2Potential FDA Approval of "Pink Viagra" Sends Wrong Message 3Potential FDA Approval of "Pink Viagra" Sends Wrong Message 4Potential FDA Approval of "Pink Viagra" Sends Wrong Message 5Isis Reports Financial Results And Highlights For Second Quarter 2015 2Isis Reports Financial Results And Highlights For Second Quarter 2015 3Isis Reports Financial Results And Highlights For Second Quarter 2015 4Isis Reports Financial Results And Highlights For Second Quarter 2015 5Isis Reports Financial Results And Highlights For Second Quarter 2015 6Isis Reports Financial Results And Highlights For Second Quarter 2015 7Isis Reports Financial Results And Highlights For Second Quarter 2015 8Isis Reports Financial Results And Highlights For Second Quarter 2015 9Isis Reports Financial Results And Highlights For Second Quarter 2015 10Isis Reports Financial Results And Highlights For Second Quarter 2015 11Isis Reports Financial Results And Highlights For Second Quarter 2015 12Isis Reports Financial Results And Highlights For Second Quarter 2015 13Isis Reports Financial Results And Highlights For Second Quarter 2015 14Isis Reports Financial Results And Highlights For Second Quarter 2015 15Isis Reports Financial Results And Highlights For Second Quarter 2015 16Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 2Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 3
Cached News: